AzTrials
AzTrials

Endodontically Treated TeethNCT05376033

Outcome of Root Canal Treatments Obturated With Calcium Silicate Based Sealers

A study testing root canal filling with Ceraseal sealer in people with Endodontically Treated Teeth, run by University of Bologna at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The clinical use of a flowable premixed calcium-silicate bioceramic sealer used in association with warm carrier-based/single-cone technique will be compared with epoxy resin-based sealer with carrier-based technique. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Endodontically Treated Teeth
What is being tested?
root canal filling with Ceraseal sealer
Could I receive a placebo?
No, everyone receives an active treatment
How many people
109 participants
Where
1 siteItaly
Study dates
1 Feb 2019to 1 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • age 18-75 years
  • no use of antiresorptive or antiangiogenic drug
  • healthy status (ASA 1 or 2).
  • Needing one or more root canal treatment

Who cannot join

  • Teeth with less than 2 walls of structural integrity
  • Wide apexes (>40 diameter)
  • ASA > 3,
  • Any pathology that could compromise bone healing or the immune response,
  • pregnancy or breast feeding
  • heavy smoking (>15 cigarettes/day), (Tverdal \& Bjartveit 2006)
  • exposure to radiation therapy focussed on the head and neck region and malignant disease directly involving the jaws.
  • Lacks of occlusal contacts

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Dental School University of Bologna

    Bologna, Emilia-Romagna, 40125

Other trials in Italy

About this study

The clinical use of a flowable premixed calcium-silicate bioceramic sealer used in association with warm carrier-based/single-cone technique will be compared with epoxy resin-based sealer with carrier-based technique.

Read the detailed description

Healthy consecutive patients (n= 109) requiring 141 root canal treatments were enrolled in this study and divided in 3 groups (Group 1: Ceraseal + single cone cold technique n=47. Group 2: Ceraseal + Carrier-based technique n=47. Group 3 AH Plus + Carrier based technique n=47).

Periapical X-rays were taken preoperatively, after root canal filling and after 6, 12 and 24 months. Two evaluators blindly assessed the Periapical Index (PAI) and sealer extrusion in the 3 groups (k =0.90). Healing rate and survival rate were also analysed.

Chi square tests was used to analyse significant differences among the groups. Multilevel analysis was performed to analyse the factors associated to healing status and survival status.

Being tested
root canal filling with Ceraseal sealer
Keywords
root canal treatment, healing rate, warm obturation technique, bioceramic sealer
Medical subject headings
Tooth, Nonvital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • root canal filling with Ceraseal sealerOther

    root canal filling with Ceraseal sealer

Study groups in NCT05376033
Study groupRoleWhat they receive
Premixed Sealer + Single coneExperimentalPremixed flowable hydraulic calcium silicate sealer was applied with a a K File #15 that was inserted into the canal to reach the WL - 3mm and gently moved around the root canal walls. Then, gutta-percha points were gently inserted at the WL -0.5mm and compacted with lateral condensation/vertical condensation.
Receives: Other: root canal filling with Ceraseal sealer
Premixed Sealer + ThermafilExperimentalPremixed bioceramic sealer was applied and previously described. Pre-heated carrier was inserted in the canal at WL-0.5mm. The carrier excess was removed with a Thermacut bur.
Receives: Other: root canal filling with Ceraseal sealer
Sealer + ThermafilOtherEpoxy-resin-based sealer was mixed and immediately inserted into the root canal using a K File #15. Pre-heated carrier was inserted in the canal at WL -0.5mm. The carriers excess was removed with a bur.
Receives: Other: root canal filling with Ceraseal sealer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Healing rate

    Periapical index minor than 3 at the endline

    Measured: 24 months

Secondary outcomes (1)
  1. Survival rate

    presence of root canal treated tooth at the endline

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 May 2022
  2. Study start1 Feb 2019
  3. Primary completion1 Feb 2022
  4. Study completion1 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
109 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05376033
Sponsor's protocol ID
OUTENDOPROSP
Status last verified
May 2022
First submitted
3 May 2022
Last updated
17 May 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing root canal filling with Ceraseal sealer in people with Endodontically Treated Teeth, run by University of Bologna at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Healing rate (time frame: 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in